Please Wait.....
Report
Cell and Gene Therapy Tools and Reagents: Global Markets
Market Research Report I 2026-02-05 I 175 Pages I BCC Research
Description
Report Scope
The report provides an overview of the global market for cell and gene therapy tools and reagents. It includes global revenue ($ millions) for the base year 2024, estimated data for 2025, and forecast data from 2026 through 2030. In this report, the market is segmented based on product type, application and end user. By product type, the market is segmented into vectors, GMP proteins, GMP antibodies, GMP small molecules, bioreactors, multiplex immunoassays, immunoassays, leukapheresis, cell separation, cell expansion, cytokine release syndrome (CRS) monitoring, cryopreservation and media.
The application segment covered cancer, rare diseases and other diseases. By end user, the market is divided into pharmaceutical and biotechnology companies, academic research institutes, and clinical laboratories.
The regions covered in this study are North America, Europe, Asia-Pacific and rest of the World (RoW) (which includes the Middle East and Africa and South America), with analysis of the markets in the U.S., Canada, Mexico, Germany, the U.K., Italy, France, Spain, the rest of Europe, China, Japan, India, South Korea and the rest of Asia-Pacific. The report covers the trends and challenges that affect the market. It includes an analysis of the competitive landscape, with the ranking of leading companies and their market shares. The report also has a dedicated section of company profiles that covers details of leading companies. It analyzes companies' environmental, social and corporate governance (ESG) initiatives.
Report Includes
- 77 data tables and 55 additional tables
- An overview of the global market for cell and gene therapy tools and reagents
- In-depth analysis of global market trends, featuring historical revenue data for 2022-2025. This analysis includes projections of compound annual growth rates (CAGRs) through 2030
- Evaluation of the current market size and revenue growth prospects specific to the cell and gene therapy tools and reagents market, accompanied by a market share analysis by type, application, end user, and region
- Analysis of current and future demand in the cell and gene therapy tools and reagents market, along with a detailed analysis of the competitive environment, market regulations and reimbursement practices
- Discussion of the prevalence of infectious disease, metabolic disorders and chronic ailments, along with the recent technological advances, competitive landscape, and the industry value chain
- Analysis of drivers, challenges, and opportunities affecting market growth
- Coverage of evolving technologies, the current and future market potential, R&D activities, growth strategies, new product pipeline, regulatory framework and reimbursement scenarios, and ESG trends of the market
- Market share analysis of the key market participants in the industry, along with their research priorities, product portfolios, global rankings and company competitive landscape
- Profiles of major companies within the industry, including Thermo Fisher Scientific Inc., Cytiva (Danaher Corp.), Merck KGaA, Miltenyi Biotec, and Sartorius AG
Executive Summary
Summary:
The global market for cell and gene therapy tools and reagents is expected to grow from $12 billion in 2025 and is projected to reach $19.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 10.6% during the forecast period of 2025 to 2030.
Cell and gene therapies (CGTs) utilize cellular or genetic resources to treat or prevent diseases, offering a developing translational technique in precision medicine that has the potential to cure diseases that were previously considered incurable.
According to the article by Jian et al. (2025), published in Cancer Letters, since 2021, the global market for cell and gene therapy tools and reagents has experienced rapid growth. In 2024, there were REDACTED cell and gene therapy (CGT) developers, representing a 6% yearly increase. Currently, REDACTED clinical studies are active, in the areas of rare diseases (REDACTED%) and oncology (REDACTED%). Multiple approvals from global regulators highlighted significant achievements in 2024.
The U.S. Food and Drug Administration (FDA), China's National Medical Products Administration (NMPA), the European Union's European Medicines Agency (EMA) and Japan's Pharmaceuticals and Medical Devices Agency (PMDA) have approved a record 13 novel cell and gene therapies (CGTs), making 2024 a pivotal year for therapeutic advances in human diseases. The first Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) therapy, the first magnetic resonance imaging (MRI)-guided intracranial adeno-associated virus (AAV) delivery gene therapy and the first tumor infiltration lymphocyte therapy are a few developments that occurred in 2024. These developments marked the beginning of a whole new phase in the practical application of advances in gene editing and cell technologies.
The growing focus on clinical and commercial activities in the CGT sector is expected to drive the global market for cell and gene therapy tools and reagents.
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Overview
Current Market Scenario
Segmental Analysis
Regional Market Insights
Emerging Technologies
Conclusion
Chapter 2 Market Overview
Cell and Gene Therapy Overview
Cell Therapy
Gene Therapy
Types of Cell and Gene Therapy
Gene Therapy
Cell Therapy
Common Equipment Used
Approved Cell and Gene Therapy Products
Macroeconomic Factors Analysis
Demographic Factors
Geopolitical Factors
Impact of U.S. Tariffs
Porter's Five Forces Analysis
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Increasing Investments in CGT Research
Expanding Clinical and Commercial CGT Products
Rising Demand for Precision Medicine
Capacity Expansions for Clinical and Commercial Manufacturing
Growing Number of Strategic Initiatives
Rising Aging Population and the Increasing Prevalence of Chronic Diseases
Market Restraints/Challenges
Complex Manufacturing and Supply Chain
High Cost of Development
Lack of Skilled Workforce
Regulatory Hurdles
Market Opportunities
Rising Demand for CGTs in Emerging Countries
Growing Demand for Off-the-Shelf Products
Chapter 4 Regulatory Landscape
Overview
U.S.
Cell Therapy Regulations
Gene Therapy Regulations
Viral and Non-Viral Vectors
Media
GMP Proteins and Antibodies
Leukapheresis
Europe
Asia-Pacific
Chapter 5 Emerging Technologies and Developments
Key Takeaways
Closed and Automated Systems
Single-Use Technologies and Miniaturization
Chapter 6 Market Segmentation Analysis
Segmentation Breakdown
Market Analysis by Product Type
Key Takeaways
Immunoassays
Bioreactors
Leukapheresis
GMP Antibodies
Multiplex Immunoassays
Vectors
Cell Separation
Cryopreservation
Cell Expansion
Media
GMP Proteins
GMP Small Molecules
CRS Monitoring
Market Analysis by Application
Key Takeaways
Cancer
Rare Diseases
Other Diseases
Market Analysis by End User
Key Takeaways
Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Clinical Laboratories
Geographic Breakdown
Market Analysis by Region
Key Takeaways
North America
Europe
Asia-Pacific
Rest of the World
Chapter 7 Competitive Intelligence
Key Takeaways
Competitive Analysis
Strategic Initiatives
Agreements, Collaborations and Partnerships
Acquisitions
Investments and Expansions
Chapter 8 Sustainability in Global Market for Cell and Gene Therapy Tools and Reagents: An ESG Perspective
Introduction to ESG
Sustainability Trends and Company Initiatives
Environmental Factors
Social Factors
Governance Factors
Social and Governance Initiatives
Concluding Remarks
Chapter 9 Appendix
Research Methodology
Sources
Abbreviations
Company Profiles
ABCAM LTD.
ADVERUM BIOTECHNOLOGIES INC.
AKRON BIOTECH
BIO-RAD LABORATORIES INC.
BIO-TECHNE
CYTIVA
FUJIFILM IRVINE SCIENTIFIC (FUJIFILM BIOSCIENCES)
MERCK KGAA
MILTENYI BIOTEC
PROTEINTECH GROUP INC.
QIAGEN
REVVITY
SARTORIUS AG
STEMCELL TECHNOLOGIES
THERMO FISHER SCIENTIFIC INC.
Emerging Startups/Market Disruptors
List of Tables
Summary Table : Global Market for Cell and Gene Therapy Tools and Reagents, by Region, Through 2030
Table 1 : Approved Cell and Gene Therapy Products, as of October 2025
Table 2 : Incidence and Mortality Rates of Cancer Across Regions, 2022
Table 3 : Regulations for Advanced Therapies in the Asia-Pacific Region, 2025
Table 4 : Global Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
Table 5 : Global Market for Cell and Gene Therapy Tools and Reagents for Immunoassays, by Region, Through 2030
Table 6 : Global Market for Cell and Gene Therapy Tools and Reagents for Bioreactors, by Region, Through 2030
Table 7 : Global Market for Cell and Gene Therapy Tools and Reagents for Leukapheresis, by Region, Through 2030
Table 8 : Global Market for Cell and Gene Therapy Tools and Reagents for GMP Antibodies, by Region, Through 2030
Table 9 : Global Market for Cell and Gene Therapy Tools and Reagents for Multiplex Immunoassays, by Region, Through 2030
Table 10 : Global Market for Cell and Gene Therapy Tools and Reagents for Vectors, by Region, Through 2030
Table 11 : Global Market for Cell and Gene Therapy Tools and Reagents for Cell Separation, by Region, Through 2030
Table 12 : Global Market for Cell and Gene Therapy Tools and Reagents for Cryopreservation, by Region, Through 2030
Table 13 : Global Market for Cell and Gene Therapy Tools and Reagents for Cell Expansion, by Region, Through 2030
Table 14 : Global Market for Cell and Gene Therapy Tools and Reagents for Media, by Region, Through 2030
Table 15 : Global Market for Cell and Gene Therapy Tools and Reagents for GMP Proteins, by Region, Through 2030
Table 16 : Global Market for Cell and Gene Therapy Tools and Reagents for GMP Small Molecules, by Region, Through 2030
Table 17 : Global Market for Cell and Gene Therapy Tools and Reagents for CRS Monitoring, by Region, Through 2030
Table 18 : Global Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
Table 19 : Global Market for Cell and Gene Therapy Tools and Reagents for Cancer, by Region, Through 2030
Table 20 : Global Market for Cell and Gene Therapy Tools and Reagents for Rare Diseases, by Region, Through 2030
Table 21 : Global Market for Cell and Gene Therapy Tools and Reagents for Other Diseases, by Region, Through 2030
Table 22 : Global Market for Cell and Gene Therapy Tools and Reagents, by End User, Through 2030
Table 23 : Global Market for Cell and Gene Therapy Tools and Reagents for Pharmaceutical and Biotechnology Companies, by Region, Through 2030
Table 24 : Global Market for Cell and Gene Therapy Tools and Reagents for Academic and Research Institutes, by Region, Through 2030
Table 25 : Global Market for Cell and Gene Therapy Tools and Reagents for Clinical Laboratories, by Region, Through 2030
Table 26 : Global Market for Cell and Gene Therapy Tools and Reagents, by Region, Through 2030
Table 27 : North American Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
Table 28 : North American Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
Table 29 : North American Market for Cell and Gene Therapy Tools and Reagents, by End User, Through 2030
Table 30 : North American Market for Cell and Gene Therapy Tools and Reagents, by Country, Through 2030
Table 31 : U.S. Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
Table 32 : U.S. Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
Table 33 : Canadian Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
Table 34 : Canadian Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
Table 35 : Mexican Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
Table 36 : Mexican Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
Table 37 : European Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
Table 38 : European Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
Table 39 : European Market for Cell and Gene Therapy Tools and Reagents, by End User, Through 2030
Table 40 : European Market for Cell and Gene Therapy Tools and Reagents, by Country, Through 2030
Table 41 : German Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
Table 42 : German Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
Table 43 : U.K. Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
Table 44 : U.K. Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
Table 45 : French Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
Table 46 : French Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
Table 47 : Spanish Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
Table 48 : Spanish Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
Table 49 : Italian Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
Table 50 : Italian Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
Table 51 : Rest of Europe Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
Table 52 : Rest of Europe Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
Table 53 : Asia-Pacific Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
Table 54 : Asia-Pacific Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
Table 55 : Asia-Pacific Market for Cell and Gene Therapy Tools and Reagents, by End User, Through 2030
Table 56 : Asia-Pacific Market for Cell and Gene Therapy Tools and Reagents, by Country, Through 2030
Table 57 : Chinese Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
Table 58 : Chinese Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
Table 59 : Japanese Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
Table 60 : Japanese Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
Table 61 : Indian Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
Table 62 : Indian Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
Table 63 : South Korean Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
Table 64 : South Korean Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
Table 65 : Rest of Asia-Pacific Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
Table 66 : Rest of Asia-Pacific Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
Table 67 : RoW Market for Cell and Gene Therapy Tools and Reagents, by Product Type, Through 2030
Table 68 : RoW Market for Cell and Gene Therapy Tools and Reagents, by Application, Through 2030
Table 69 : RoW Market for Cell and Gene Therapy Tools and Reagents, by End User, Through 2030
Table 70 : RoW Market for Cell and Gene Therapy Tools and Reagents, by Sub-Region, Through 2030
Table 71 : Global Ranking of Companies: Cell and Gene Therapy Tools and Reagents Market, 2024
Table 72 : Agreements, Collaborations and Partnerships: Global Market for Cell and Gene Therapy Tools and Reagents, 2021 - 2025
Table 73 : Acquisitions: Global Market for Cell and Gene Therapy Tools and Reagents, 2022 - 2025
Table 74 : VC Investments and Expansion Activities: Global Market for Cell and Gene Therapy Tools and Reagents, 2022 - 2025
Table 75 : ESG: Environmental Overview
Table 76 : Key Social and Governance Issues in the Global Market for Cell and Gene Therapy Tools and Reagents
Table 77 : Information Sources Used for this Report
Table 78 : Abbreviations Used in this Report
Table 79 : Abcam Ltd.: Company Snapshot
Table 80 : Abcam Ltd.: Product Portfolio
Table 81 : Abcam Ltd.: News/Key Developments, 2022 - 2023
Table 82 : Adverum Biotechnologies Inc.: Company Snapshot
Table 83 : Adverum Biotechnologies Inc.: Financial Performance, FY 2023 and 2024
Table 84 : Adverum Biotechnologies Inc.: Product Portfolio
Table 85 : Adverum Biotechnologies Inc.: News/Key Developments, 2022 - 2025
Table 86 : Akron Biotech: Company Snapshot
Table 87 : Akron Biotech: Product Portfolio
Table 88 : Akron Biotech: News/Key Developments, 2022 - 2025
Table 89 : Bio-Rad Laboratories Inc.: Company Snapshot
Table 90 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2023 and 2024
Table 91 : Bio-Rad Laboratories Inc.: Product Portfolio
Table 92 : Bio-Rad Laboratories Inc.: News/Key Developments, 2021 - 2025
Table 93 : Bio-Techne: Company Snapshot
Table 94 : Bio-Techne: Financial Performance, FY 2023 and 2024
Table 95 : Bio-Techne: Product Portfolio
Table 96 : Bio-Techne: News/Key Developments, 2022 - 2025
Table 97 : Cytiva: Company Snapshot
Table 98 : Cytiva: Product Portfolio
Table 99 : Cytiva: News/Key Developments, 2021 - 2024
Table 100 : FUJIFILM Irvine Scientific (FUJIFILM Biosciences): Company Snapshot
Table 101 : FUJIFILM Irvine Scientific (FUJIFILM Biosciences): Product Portfolio
Table 102 : FUJIFILM Irvine Scientific (FUJIFILM Biosciences) : News/Key Developments, 2022 - 2025
Table 103 : Merck KGaA: Company Snapshot
Table 104 : Merck KGaA: Financial Performance, FY 2023 and 2024
Table 105 : Merck KGaA: Product Portfolio
Table 106 : Merck KGaA: News/Key Developments, 2023 - 2025
Table 107 : Miltenyi Biotec: Company Snapshot
Table 108 : Miltenyi Biotec: Product Portfolio
Table 109 : Miltenyi Biotec: News/Key Developments, 2023 - 2024
Table 110 : Proteintech Group Inc.: Company Snapshot
Table 111 : Proteintech Group Inc.: Product Portfolio
Table 112 : Qiagen: Company Snapshot
Table 113 : Qiagen: Financial Performance, FY 2023 and 2024
Table 114 : Qiagen: Product Portfolio
Table 115 : Qiagen: News/Key Developments, 2023 - 2024
Table 116 : Revvity: Company Snapshot
Table 117 : Revvity: Financial Performance, FY 2023 and 2024
Table 118 : Revvity: Product Portfolio
Table 119 : Revvity: News/Key Developments, 2023 - 2025
Table 120 : Sartorius AG: Company Snapshot
Table 121 : Sartorius AG: Financial Performance, FY 2023 and 2024
Table 122 : Sartorius AG: Product Portfolio
Table 123 : Sartorius AG: News/Key Developments, 2023 - 2024
Table 124 : STEMCELL Technologies: Company Snapshot
Table 125 : STEMCELL Technologies: Product Portfolio
Table 126 : STEMCELL Technologies: News/Key Developments, 2022 - 2025
Table 127 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 128 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024
Table 129 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 130 : Thermo Fisher Scientific Inc.: News/Key Developments, 2022 - 2025
Table 131 : Emerging Startups in the Global Market for Cell and Gene Therapy Tools and Reagents
List of Figures
Summary Figure : Global Market Shares for Cell and Gene Therapy Tools and Reagents, by Region, 2024
Figure 1 : Porter's Five Forces Analysis of the Global Market for Cell and Gene Therapy Tools and Reagents
Figure 2 : Market Dynamics Snapshot of Cell and Gene Therapy Tools and Reagents
Figure 3 : Market Investments for Cell and Gene Therapy, by Year, 2019-2024
Figure 4 : Market Investments for Cell and Gene Therapy, by Deal Type, H1 2025
Figure 5 : Global Market Shares for Cell and Gene Therapy Tools and Reagents, by Product Type, 2024
Figure 6 : Global Market Shares for Cell and Gene Therapy Tools and Reagents, by Application, 2024
Figure 7 : Global Market Shares for Cell and Gene Therapy Tools and Reagents, by End User, 2024
Figure 8 : Global Market Shares for Cell and Gene Therapy Tools and Reagents, by Region, 2024
Figure 9 : North American Market Shares for Cell and Gene Therapy Tools and Reagents, by Country, 2024
Figure 10 : European Market Shares for Cell and Gene Therapy Tools and Reagents, by Country, 2024
Figure 11 : Asia-Pacific Market Shares for Cell and Gene Therapy Tools and Reagents, by Country, 2024
Figure 12 : RoW Market Shares for Cell and Gene Therapy Tools and Reagents, by Sub-Region, 2024
Figure 13 : Bio-Rad Laboratories Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 14 : Bio-Rad Laboratories Inc.: Revenue Shares, by Country/Region, FY 2024
Figure 15 : Bio-Techne: Revenue Shares, by Business Unit, FY 2024
Figure 16 : Bio-Techne: Revenue Shares, by Country/Region, FY 2024
Figure 17 : Merck KGaA: Revenue Shares, by Business Unit, FY 2024
Figure 18 : Merck KGaA: Revenue Shares, by Country/Region, FY 2024
Figure 19 : Qiagen: Revenue Shares, by Business Unit, FY 2024
Figure 20 : Qiagen: Revenue Shares, by Country/Region, FY 2024
Figure 21 : Revvity: Revenue Shares, by Business Unit, FY 2024
Figure 22 : Revvity: Revenue Shares, by Country/Region, FY 2024
Figure 23 : Sartorius AG: Revenue Shares, by Business Unit, FY 2024
Figure 24 : Sartorius AG: Revenue Shares, by Country/Region, FY 2024
Figure 25 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2024
Figure 26 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2024
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security